glp 1 agonists and inflammation GLP-1 Drugs: For Multiple Chronic Conditions A newly published case series
Description
Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrn B, Sjholm A
Epub 2025 Oct 1
There are clinical trials evaluating if these GLP-1 and multi-agonists can address neurodegeneration, addiction, inflammation, and beyond
GLP1 also delays gastric emptying and increases satiety
Mistake 9: Not having a plan beyond the starting dose
Part D plan sponsors needed to apply to participate in the model by April 20, 2026
